<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Tourette syndrome: Pathogenesis, clinical features, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Tourette syndrome: Pathogenesis, clinical features, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Tourette syndrome: Pathogenesis, clinical features, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph Jankovic, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas R Nordli, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 06, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Tourette syndrome (TS) is a neurologic disorder manifested by motor and phonic tics with onset during childhood. This topic will review the pathogenesis, clinical features, evaluation, and diagnosis of TS. The management of TS is reviewed separately. (See  <a class="medical medical_review" href="/d/html/126069.html" rel="external">"Tourette syndrome: Management"</a>.)</p><p>Other hyperkinetic movement disorders are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/6232.html" rel="external">"Hyperkinetic movement disorders in children"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>TS is thought to result from a complex interaction between social and environmental factors and multiple genetic risk factors.</p><p class="headingAnchor" id="H2412570411"><span class="h2">Pathophysiology</span><span class="headingEndMark"> — </span>TS likely results from a disturbance in the cortico-striatal-thalamic-cortical (mesolimbic) circuit, which leads to disinhibition of the motor and limbic system [<a href="#rid1">1-3</a>]. However, the precise anatomic localization for the expression of tics is still uncertain.</p><p>Advanced neuroimaging studies have found evidence of structural, functional, and metabolic changes in the brain associated with TS [<a href="#rid4">4-10</a>]. Reductions in caudate volume are the most commonly reported structural changes [<a href="#rid7">7,11,12</a>]. Positron emission tomography (PET) studies have shown variable rates of glucose utilization in the basal ganglia in patients with TS compared with controls [<a href="#rid8">8</a>]. Based on functional magnetic resonance imaging (MRI) studies, the insula plays a key role in premonitory sensations and urges, often preceding motor or phonic tics [<a href="#rid9">9,10</a>].</p><p>Neuropathologic examinations have detected no consistent brain abnormalities in patients with TS, although one report found a reduction in cholinergic and inhibitory GABAergic interneurons in the striatum of patients with TS compared with controls [<a href="#rid13">13</a>]. Various functional imaging studies have implicated GABAergic impairment in patients with TS [<a href="#rid14">14,15</a>].</p><p>Although it has been proposed that antibodies to basal ganglia neurons from group A streptococcal infection may contribute to pathogenesis of TS in some patients, there is little or no evidence that pediatric autoimmune neuropsychiatric disorder associated with group A streptococci (PANDAS) plays a role in the development of TS. This issue is discussed separately. (See  <a class="medical medical_review" href="/d/html/8046.html" rel="external">"Complications of streptococcal tonsillopharyngitis", section on 'PANDAS syndrome'</a>.)</p><p class="headingAnchor" id="H1414193358"><span class="h2">Genetics</span><span class="headingEndMark"> — </span>Despite a large number of genetic studies, no single or even multiple causative genes for TS have been identified [<a href="#rid16">16</a>]. In some cases a bilineal transmission (inheritance from both parents) is clearly evident [<a href="#rid17">17</a>].</p><p>Although the genetic basis remains elusive, several loci have been identified as candidate susceptibility regions [<a href="#rid18">18</a>]. The discovery of a mutation in the <em>SLITRK1</em> gene on chromosome 13q31.1 was a major advance in the search for the elusive TS gene or genes [<a href="#rid19">19</a>]. The <em>SLITRK1</em> gene is expressed in brain regions previously implicated in TS (cortex, hippocampus, thalamus, subthalamic nucleus, globus pallidus, striatum, and cerebellum) and it appears to play a role in dendritic growth. However, it is not clear how the altered gene product leads to the complex neurobehavioral disorder. This mutation appears to be a rare cause of TS, as it has not been found in hundreds of patients with TS tested.</p><p>Another possible rare genetic cause of TS is a mutation in the histidine decarboxylase (<em>HDC</em>) gene on chromosome 15q21-q22, as detected in two generations of a family with apparent autosomal dominant inheritance of TS [<a href="#rid20">20</a>]. The <em>HDC</em> gene encodes for L-histidine decarboxylase, which is the rate-limiting enzyme that catalyzes the biosynthesis of histamine from histidine. In the central nervous system, histaminergic neurons are located in the posterior hypothalamus but have widespread axonal connections to other brain regions [<a href="#rid21">21</a>]. These findings suggest the possibility of using pharmacologic manipulation of histaminergic neurotransmission to treat TS [<a href="#rid20">20</a>]. However, it is unknown how histamine abnormalities might cause or contribute to TS symptoms.</p><p class="headingAnchor" id="H1717219457"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The estimated global prevalence of TS derived from population-based studies is 0.5 percent [<a href="#rid22">22,23</a>]. TS affects males more often than females by a ratio of approximately 4:1 [<a href="#rid24">24-28</a>]. Most but not all reports suggest that the prevalence of TS is similar among different racial and ethnic groups [<a href="#rid29">29</a>], with the exception that TS appears to be uncommon or rare among African Americans and sub-Saharan Black Africans [<a href="#rid30">30</a>].</p><p>Prenatal maternal smoking may be associated with an increased risk for TS [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H3"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H4"><span class="h2">Tics</span><span class="headingEndMark"> — </span>Tics are the clinical hallmark of TS. Tics are sudden, brief, intermittent movements (motor tics) or utterances (phonic tics). Tics have been considered involuntary, but tics can temporarily be voluntarily suppressed. Most patients with TS also have comorbid problems such as attention deficit hyperactivity disorder (ADHD) or obsessive-compulsive disorder (OCD). (See <a class="local">'Comorbidities'</a> below.)</p><p class="headingAnchor" id="H680014173"><span class="h3">Tic classification</span><span class="headingEndMark"> — </span>The tics in TS can be categorized as motor or phonic (ie, vocal), and as either simple or complex.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Motor tics</strong> – Simple motor tics include eye blinking, facial grimacing, shoulder shrugging, and head jerking. Complex motor tics involve sequences of coordinated movements, including bizarre gait, kicking, jumping, body gyrations, scratching, seductive gestures, copropraxia (obscene gestures), and echopraxia (mimicking of gestures). Some motor tics may be dystonic; examples include oculogyric movements, sustained mouth opening, torticollis, and body postures [<a href="#rid32">32,33</a>]. Other motor tics may be tonic in nature; examples include immobility, staring, and prolonged contraction of abdominal muscles.</p><p></p><p class="bulletIndent1">Violent or forceful neck tics in patients with TS rarely have been associated with injuries including cervical disc herniation, compressive and noncompressive myelopathy, and cervical artery dissection with stroke [<a href="#rid34">34-39</a>]. Thus, some experts advocate more aggressive management of severe forceful neck tics, including the use of botulinum toxin injections or even deep brain stimulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Phonic tics</strong> – Simple phonic tics include grunting, barking, moaning, throat clearing, sniffing, hollering, and other noises. Complex phonic tics include coprolalia (obscene words), echolalia (repetition of words), and palilalia (repetition of a phrase or word with increasing rapidity). Coprolalia occurs in less than 20 percent of cases and is usually in a form of uttering obscenities (foul, repulsive language, often with sexual or scatologic meaning) rather than profanity (cursing or cussing with religious meaning), although some have racist, sexist, or vulgar meaning [<a href="#rid40">40,41</a>]. The obscene words are often shortened rather than spoken in full.</p><p></p><p class="headingAnchor" id="H451280662"><span class="h3">Tic characteristics</span><span class="headingEndMark"> — </span>One of the most characteristic features of tics is the presence of premonitory feelings or sensations, which are relieved by the execution of the tic, the irresistible urge before and relief after a tic [<a href="#rid42">42</a>]. Other tic characteristics include the presence of precipitating factors, temporary suppressibility, variable severity, a waxing and waning nature, and evolution of an individual's tic repertoire over time [<a href="#rid32">32</a>]. Some tics will abate, only to be replaced by newer tics or by older tics that had been in remission.</p><p>Precipitating or exacerbating factors may include psychosocial stress, anxiety, anger, excitement, fatigue, and illness [<a href="#rid32">32,43</a>]. Studies are conflicting on whether tic severity differs between males and females [<a href="#rid27">27,28</a>].</p><p class="headingAnchor" id="H2990047332"><span class="h3">Onset and natural history</span><span class="headingEndMark"> — </span>The onset of TS is typically between 2 and 15 years, although the diagnosis may be delayed until 21 years in some cases. The average age at onset is approximately 6 years [<a href="#rid24">24,44</a>], and the disorder is manifested by age 11 years in 96 percent of patients [<a href="#rid45">45</a>]. The severity of tics usually reaches a peak between the ages of 10 to 12 years, followed by improvement in the majority during adolescent years and adulthood [<a href="#rid46">46,47</a>]. A useful approximation suggests that one-third of tics resolve completely, one-third improve, and one-third continue without abatement [<a href="#rid3">3,47</a>].</p><p>Prospective studies in both tertiary care centers and population-based cohorts largely validate these estimates [<a href="#rid48">48,49</a>]. Overall, the risk of moderate to severe tics in adults with a history of childhood tic disorder is approximately 20 to 25 percent. Many of the remaining patients continue to experience tics, but they are mild and nondisabling. Risk factors for persistence of moderate to severe tics include psychiatric comorbidities during childhood (eg, OCD, ADHD) and a family history of neuropsychiatric disorders, especially tics and anxiety, in first-degree relatives [<a href="#rid48">48,49</a>].</p><p>While tics may persist into adulthood, their severity gradually diminishes over time in 40 to 45 percent of cases [<a href="#rid4">4,50</a>]. The most common cause of "adult-onset" tics is TS that remits after puberty and reappears as tics later in life [<a href="#rid51">51</a>]. Other causes of tics seen in adults are less common [<a href="#rid52">52</a>].</p><p class="headingAnchor" id="H5"><span class="h2">Comorbidities</span><span class="headingEndMark"> — </span>Comorbidity in TS is frequent [<a href="#rid53">53</a>] and imposes a significant additional burden to patients with TS [<a href="#rid32">32</a>]. Most patients with TS have one or more comorbid conditions.</p><p>In a large international registry of 3500 patients with TS, comorbid conditions included ADHD (60 percent), OCD (27 percent), obsessive-compulsive behavior (32 percent), learning disorder (23 percent), and conduct disorder/oppositional defiant disorder (15 percent) [<a href="#rid24">24</a>]. Patients with more comorbidities were more likely to have behavioral problems such as sleep difficulties, coprolalia, self-injurious behavior, and anger control problems. One study showed that self-injurious behavior is present in approximately 17 percent of patients with TS [<a href="#rid54">54</a>]. Motor and phonic manifestations were more frequent in boys, whereas girls were more likely to have behavioral problems such as OCD. Only 12 percent of patients with TS had no comorbid conditions.</p><p>The association of behavior disorders with tics in a community-based study was similar to clinic-based reports. In a study of school children aged 9 to 17 years, OCD, ADHD, anxiety disorders, and mood disorders were significantly more common in children with than without tics and with than without TS [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H2204431404"><span class="h3">Attention deficit hyperactivity disorder</span><span class="headingEndMark"> — </span>ADHD affects 30 to 60 percent of patients with TS [<a href="#rid24">24,32,53,55,56</a>]. Symptoms of ADHD often emerge two to three years before the onset of tics [<a href="#rid57">57</a>]. The presence of ADHD in TS is associated with difficulties in planning, working memory, visual attention, learning, and school performance, and with diminished functional ability [<a href="#rid56">56,58</a>]. (See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/1232.html" rel="external">"Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p>ADHD may mediate an increased risk for driving-related accidents in adults with TS compared with the general population [<a href="#rid59">59</a>]. However, motor tics, such as frequent blinking and transient blepharospasm (dystonic tic) and complex limb and truncal tics, may also seriously impair driving abilities of patients with TS [<a href="#rid60">60</a>]. Comorbid ADHD has also been associated with increased likelihood of cigarette smoking, alcohol use, and illegal substance use in adolescents with TS [<a href="#rid61">61</a>].</p><p class="headingAnchor" id="H1492985536"><span class="h3">Obsessive-compulsive disorder</span><span class="headingEndMark"> — </span>OCD affects 10 to 50 percent of patients with TS [<a href="#rid53">53,55</a>]. Symptoms typically emerge a few years after the onset of tics and often become more severe over time [<a href="#rid32">32,62-64</a>]. Compulsions or rituals may include repetitive counting, arranging, hoarding, touching, tapping, rubbing, and error checking. Patients may have bizarre thoughts, urges, ruminations, or images of an aggressive, sexual, or religious nature. Individuals without TS who have OCD more commonly have compulsions involving contamination and cleaning. (See  <a class="medical medical_review" href="/d/html/86436.html" rel="external">"Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/498.html" rel="external">"Obsessive-compulsive disorder in adults: Epidemiology, clinical features, and diagnosis"</a>.)</p><p>The expression of OCD in TS can affect the execution of tics so that they occur in a particular manner and order (eg, a certain number of times, being symmetric, involving both sides of the body) and stop only after a particular "just right" feeling is achieved [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H203215544"><span class="h3">Other behavioral and psychosocial problems</span><span class="headingEndMark"> — </span>In addition to ADHD and OCD, patients with TS are at increased risk for a number of behavioral and psychosocial problems, including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anxiety disorders</strong> – In a report of 1374 patients with TS, the lifetime prevalence of anxiety disorders was approximately 30 percent [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/d/html/15926.html" rel="external">"Anxiety disorders in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, and course"</a> and  <a class="medical medical_review" href="/d/html/496.html" rel="external">"Generalized anxiety disorder in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mood disorders and risk of suicide</strong> – Patients with TS have an increased risk of mood disorders [<a href="#rid65">65</a>], with a lifetime prevalence of approximately 30 percent in the report of 1374 patients with TS [<a href="#rid53">53</a>]. Mood disorders associated with TS are more prevalent in adolescents and adults compared with children and may be associated with greater tic severity.</p><p></p><p class="bulletIndent1">In a case-control study, children with TS (n = 1337) had a much higher risk of developing depression compared with matched controls (hazard ratio 4.85, 95% CI 3.46-6.79) [<a href="#rid65">65</a>]. Another case-control study of 7736 patients with TS and chronic tic disorders found that TS was associated with an increased risk of suicide (odds ratio [OR] 4.39, 95% CI 2.89-6.67) and attempted suicide (OR 3.86, 95% CI 3.50-4.26) [<a href="#rid66">66</a>]. The risk of suicide was increased among subjects with previous suicide attempts and those with persistence of tics beyond young adulthood. (See  <a class="medical medical_review" href="/d/html/1229.html" rel="external">"Suicidal behavior in children and adolescents: Epidemiology and risk factors"</a> and  <a class="medical medical_review" href="/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disruptive behaviors</strong> – Episodes of behavioral outbursts, rage attacks, and aggression are common problems in patients with TS [<a href="#rid53">53,67,68</a>]. In the report of 1374 patients with TS, the lifetime prevalence of disruptive behaviors was approximately 30 percent [<a href="#rid53">53</a>]. These episodes, as well as other disruptive behavior associated with TS (eg, obscene language, swearing, cursing or gestures, impulse control problems, inappropriate obsessions), may increase the risk of encountering legal disciplinary action. The occurrence of assault and criminal behavior among patients with TS is rare, but patients are at increased risk compared with the general population [<a href="#rid69">69,70</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Learning disabilities and poor school performance</strong> – Learning disorders are common among patients with TS [<a href="#rid24">24</a>]. Contributing factors include ADHD, OCD, disruptive tics, and adverse effects of medications [<a href="#rid32">32,71,72</a>]. A cohort study from Sweden with over two million individuals found that subjects diagnosed with TS or chronic tic disorder (n = 3590) were more likely to experience academic underachievement across all educational levels, even after adjusting for neuropsychiatric comorbid conditions and other confounding factors [<a href="#rid73">73</a>].</p><p></p><p class="headingAnchor" id="H2636436370"><span class="h3">Sleep disorders</span><span class="headingEndMark"> — </span>Patients with TS commonly have sleep complaints and comorbid sleep disorders, including insomnia, excessive daytime sleepiness, disorders of arousal (eg, sleepwalking, sleeptalking, sleep terrors, enuresis), and bruxism [<a href="#rid40">40,74,75</a>]. Motor tics persist during sleep in the majority of patients, predominantly during rapid eye movement (REM) sleep [<a href="#rid75">75</a>].</p><p class="headingAnchor" id="H1948428326"><span class="h3">Additional associations</span><span class="headingEndMark"> — </span>One population-based cohort study reported that adults and children with TS have an increased risk of obesity, type 2 diabetes, and cardiovascular disorders [<a href="#rid76">76</a>]. Limited data suggest that patients with TS have an increased prevalence of migraine, tension-type headache, and cervical spine disorders compared with the general population [<a href="#rid77">77-80</a>].</p><p class="headingAnchor" id="H1250925940"><span class="h1">EVALUATION AND DIAGNOSIS</span></p><p class="headingAnchor" id="H6"><span class="h2">History and examination</span><span class="headingEndMark"> — </span>The evaluation of a patient with suspected TS should include a careful review of the medical, social, and family histories for tics or tic-related disorders. The clinician should assess tic classification and characteristics by history and by observation, either directly or by video recording, as this is key to the diagnosis. The evaluation should also assess the degree of functional impairment caused by tics and comorbid disorders, as this is essential to the management [<a href="#rid56">56</a>]. Tic severity can be measured using a validated scale, such as the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fpandasnetwork.org%2Fwp-content%2Fuploads%2F2018%2F11%2FYGTSS.pdf&amp;token=l0ERyLEaZYUzkzmjqxvxmL9QNCdV4e%2FPascKnHgS4URvlNuRjte4S%2BTMwa3zBV06jHEWcsV4b9FydBbNzxbNkIxstsfDD9u%2BDysr2Mhe%2B%2Fs%3D&amp;TOPIC_ID=6221" target="_blank">Yale Global Tic Severity Scale</a> [<a href="#rid56">56,81</a>].</p><p>The neurologic examination in patients with TS is often normal except for the presence of tics. However, some patients have increased rates of normal blinking [<a href="#rid82">82</a>], subtle oculomotor disturbances related to saccadic eye movements [<a href="#rid83">83</a>], or other evidence of mild impairment of motor control.</p><p class="headingAnchor" id="H7"><span class="h2">Neuroimaging</span><span class="headingEndMark"> — </span>Standard anatomic neuroimaging studies such as routine head computed tomography (CT) and brain MRI are unremarkable in patients with TS. However, volumetric MRI studies have found evidence of structural changes in the brain. (See <a class="local">'Pathophysiology'</a> above.)</p><p class="headingAnchor" id="H8"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of TS is based on the clinical features of the disease, particularly the presence of multiple motor and phonic tics, with onset before age 18 or 21, depending upon which criteria are used [<a href="#rid84">84,85</a>]. There is no diagnostic laboratory test [<a href="#rid32">32</a>]. The presence of phonic tics such as grunting is required for the diagnosis. (See <a class="local">'Diagnostic criteria'</a> below.)</p><p>The diagnosis is often supported by the presence of coexisting behavioral disorders (see <a class="local">'Comorbidities'</a> above) including attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD) [<a href="#rid40">40</a>]. A family history of similar symptoms also supports the diagnosis of TS.</p><p>The mistaken diagnosis of a functional (psychogenic) disorder may occur because of certain characteristics of the tics in patients with TS, including the waxing and waning nature, exacerbation during periods of stress and reduction during mental concentration, and the temporary suppressibility. The presence of an irresistible urge before and relief after a tic-like movement is a feature that helps define the movement as a tic and argues against a functional (psychogenic) disorder [<a href="#rid86">86</a>]. Once thought rare, functional tics have become much more frequent during the coronavirus disease 2019 (COVID-19) pandemic, occurring almost exclusively in girls, partly as a result of exposure to certain influencers on social media. (See  <a class="medical medical_review" href="/d/html/14132.html" rel="external">"Functional movement disorders", section on 'Functional tics'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Diagnostic criteria</span><span class="headingEndMark"> — </span>There is no confirmatory laboratory test for TS; the diagnosis is based on a set of clinical diagnostic criteria [<a href="#rid84">84,85,87</a>]. The Tourette Syndrome Classification Study Group criteria for a definite diagnosis of TS are as follows [<a href="#rid84">84</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Both multiple motor tics and one or more phonic tics must be present at some time during the illness, although not necessarily concurrently</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tics must occur many times a day, nearly every day, or intermittently throughout a period of more than one year</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anatomic location, number, frequency, type, complexity, or severity of tics must change over time</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Onset of tics before the age of 21 years (the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition [DSM-5] criteria [<a href="#rid85">85</a>] require onset of tics before age 18 years)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Involuntary movements and noises must not be explained by another medical condition (or by the physiologic effects of substances as per the DSM-5 [<a href="#rid85">85</a>])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Motor tics, phonic tics, or both must be witnessed by a reliable examiner at some point during the illness or be recorded by videotape or cinematography</p><p></p><p class="headingAnchor" id="H1206988437"><span class="h2">Evaluation for comorbid conditions</span><span class="headingEndMark"> — </span>Most patients with TS have comorbid neuropsychiatric disorders (see <a class="local">'Comorbidities'</a> above). Therefore, patients with TS should be evaluated for common comorbid conditions, particularly ADHD and OCD [<a href="#rid56">56</a>]. Patients should also be screened for anxiety, mood, and disruptive behavior disorders, and questioned about suicidal ideation and suicide attempts. (See  <a class="medical medical_review" href="/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/86436.html" rel="external">"Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/93408.html" rel="external">"Anxiety disorders in children and adolescents: Assessment and diagnosis"</a>.)</p><p class="headingAnchor" id="H1717219464"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Although TS is the most common cause of persistent or recurrent tics, there are many potential etiologies in the differential diagnosis [<a href="#rid88">88</a>]. The main entity is transient tics of childhood, which occur in approximately 25 percent of children [<a href="#rid40">40</a>]. Other considerations in the differential include neuroacanthocytosis, drugs such as dopamine receptor blocking agents and cocaine, pervasive developmental disorders, and insults to the basal ganglia resulting from head trauma or stroke; these and others are outlined in the table  (<a class="graphic graphic_table graphicRef61505" href="/d/graphic/61505.html" rel="external">table 1</a>) [<a href="#rid52">52</a>].</p><p>The ability to temporarily suppress tics and the premonitory sensations that often precede tics are hallmark features of TS that help to differentiate it from other hyperkinetic movement disorders such as chorea, dystonia, athetosis, myoclonus, stereotypies, and paroxysmal dyskinesia [<a href="#rid40">40,42,89,90</a>]. (See  <a class="medical medical_review" href="/d/html/6232.html" rel="external">"Hyperkinetic movement disorders in children"</a>.)</p><p>Complex motor stereotypies usually have an earlier onset than TS and, unlike TS, lack a premonitory urge, are executed in a fixed pattern with a prolonged duration and rhythmic quality, and can be stopped with cueing [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/6232.html" rel="external">"Hyperkinetic movement disorders in children", section on 'Stereotypies'</a>.)</p><p class="headingAnchor" id="H2109074372"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/121121.html" rel="external">"Society guideline links: Tourette syndrome"</a>.)</p><p class="headingAnchor" id="H6721566"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/83754.html" rel="external">"Patient education: Tourette syndrome (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H19"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Tourette syndrome (TS) is a common movement and neurobehavioral disorder in children characterized by multiple motor and phonic tics. (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – TS is thought to result from a complex interaction between social and environmental factors and multiple genetic abnormalities. Several studies suggest a disturbance in the cortico-striatal-thalamic-cortical (mesolimbic) circuit, which leads to disinhibition of the motor and limbic system. The genetic basis of TS remains elusive. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Tics are the clinical hallmark of TS.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tic characteristics</strong> – Tics are sudden, brief, intermittent movements (motor tics) or utterances (phonic tics). Most patients experience premonitory feelings or sensations, described as an irresistible urge to perform a tic, followed by relief after a tic. (See <a class="local">'Tic classification'</a> above and <a class="local">'Tic characteristics'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Onset and natural history</strong> – The onset of TS is typically between ages 2 and 15 years and occurs by 11 years of age in 96 percent of patients. The severity of tics usually reaches a peak between the ages of 10 to 12 years, followed by improvement in the majority during adolescent years and adulthood. (See <a class="local">'Onset and natural history'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Common comorbidities</strong> – Common comorbid conditions in TS include attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), and other behavioral and psychosocial problems. (See <a class="local">'Comorbidities'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of TS is based on the clinical features, particularly the presence of multiple motor and phonic tics, with onset before age 21. There is no diagnostic laboratory test. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The main entity on the differential diagnosis is transient tics of childhood, which occur in approximately 25 percent of children. Other considerations include neuroacanthocytosis, drugs such as dopamine receptor blocking agents and cocaine, pervasive developmental disorders, and insults to the basal ganglia resulting from head trauma or stroke  (<a class="graphic graphic_table graphicRef61505" href="/d/graphic/61505.html" rel="external">table 1</a>). (See <a class="local">'Differential diagnosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Thenganatt MA, Jankovic J. Recent Advances in Understanding and Managing Tourette Syndrome. F1000Res 2016; 5.</a></li><li><a class="nounderline abstract_t">Worbe Y, Marrakchi-Kacem L, Lecomte S, et al. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome. Brain 2015; 138:472.</a></li><li><a class="nounderline abstract_t">Singer HS, Augustine F. Controversies Surrounding the Pathophysiology of Tics. J Child Neurol 2019; 34:851.</a></li><li><a class="nounderline abstract_t">Robertson MM. The Gilles de la Tourette syndrome: the current status. Arch Dis Child Educ Pract Ed 2012; 97:166.</a></li><li><a class="nounderline abstract_t">Fredericksen KA, Cutting LE, Kates WR, et al. Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology 2002; 58:85.</a></li><li><a class="nounderline abstract_t">Muellner J, Delmaire C, Valabrégue R, et al. Altered structure of cortical sulci in gilles de la Tourette syndrome: Further support for abnormal brain development. Mov Disord 2015; 30:655.</a></li><li><a class="nounderline abstract_t">Plessen KJ, Bansal R, Peterson BS. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res 2009; 67:559.</a></li><li><a class="nounderline abstract_t">Pourfar M, Feigin A, Tang CC, et al. Abnormal metabolic brain networks in Tourette syndrome. Neurology 2011; 76:944.</a></li><li><a class="nounderline abstract_t">Jackson SR, Loayza J, Crighton M, et al. The role of the insula in the generation of motor tics and the experience of the premonitory urge-to-tic in Tourette syndrome. Cortex 2020; 126:119.</a></li><li><a class="nounderline abstract_t">Kleimaker M, Kleimaker A, Weissbach A, et al. Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome. Front Neurol 2020; 11:592258.</a></li><li><a class="nounderline abstract_t">Peterson BS, Thomas P, Kane MJ, et al. Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003; 60:415.</a></li><li><a class="nounderline abstract_t">Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005; 65:1253.</a></li><li><a class="nounderline abstract_t">Kataoka Y, Kalanithi PS, Grantz H, et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 2010; 518:277.</a></li><li><a class="nounderline abstract_t">Draper A, Stephenson MC, Jackson GM, et al. Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome. Curr Biol 2014; 24:2343.</a></li><li><a class="nounderline abstract_t">He JL, Mikkelsen M, Huddleston DA, et al. Frequency and Intensity of Premonitory Urges-to-Tic in Tourette Syndrome Is Associated With Supplementary Motor Area GABA+ Levels. Mov Disord 2022; 37:563.</a></li><li><a class="nounderline abstract_t">Wendt FR, Pathak GA, Lencz T, et al. Multivariate genome-wide analysis of education, socioeconomic status and brain phenome. Nat Hum Behav 2021; 5:482.</a></li><li><a class="nounderline abstract_t">O'Rourke JA, Scharf JM, Yu D, Pauls DL. The genetics of Tourette syndrome: a review. J Psychosom Res 2009; 67:533.</a></li><li><a class="nounderline abstract_t">Deng H, Gao K, Jankovic J. The genetics of Tourette syndrome. Nat Rev Neurol 2012; 8:203.</a></li><li><a class="nounderline abstract_t">Abelson JF, Kwan KY, O'Roak BJ, et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005; 310:317.</a></li><li><a class="nounderline abstract_t">Ercan-Sencicek AG, Stillman AA, Ghosh AK, et al. L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 2010; 362:1901.</a></li><li><a class="nounderline abstract_t">Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008; 88:1183.</a></li><li><a class="nounderline abstract_t">Scharf JM, Miller LL, Gauvin CA, et al. Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov Disord 2015; 30:221.</a></li><li><a class="nounderline abstract_t">Jafari F, Abbasi P, Rahmati M, et al. Systematic Review and Meta-Analysis of Tourette Syndrome Prevalence; 1986 to 2022. Pediatr Neurol 2022; 137:6.</a></li><li><a class="nounderline abstract_t">Freeman RD, Fast DK, Burd L, et al. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000; 42:436.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep 2009; 58:581.</a></li><li><a class="nounderline abstract_t">Knight T, Steeves T, Day L, et al. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol 2012; 47:77.</a></li><li><a class="nounderline abstract_t">Girgis J, Martino D, Pringsheim T. Influence of sex on tic severity and psychiatric comorbidity profile in patients with pediatric tic disorder. Dev Med Child Neurol 2022; 64:488.</a></li><li><a class="nounderline abstract_t">Garcia-Delgar B, Servera M, Coffey BJ, et al. Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group. Eur Child Adolesc Psychiatry 2022; 31:1539.</a></li><li class="breakAll">Stillman A, Ercan-Sencicek AG, State MW. Tourette disorder overview. GeneReviews. www.ncbi.nlm.nih.gov/books/NBK21138/ (Accessed on June 10, 2011).</li><li><a class="nounderline abstract_t">Robertson MM. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies. J Psychosom Res 2008; 65:461.</a></li><li><a class="nounderline abstract_t">Browne HA, Modabbernia A, Buxbaum JD, et al. Prenatal Maternal Smoking and Increased Risk for Tourette Syndrome and Chronic Tic Disorders. J Am Acad Child Adolesc Psychiatry 2016; 55:784.</a></li><li><a class="nounderline abstract_t">Singer HS. Tics and Tourette Syndrome. Continuum (Minneap Minn) 2019; 25:936.</a></li><li><a class="nounderline abstract_t">Baizabal-Carvallo JF, Alonso-Juarez M, Jankovic J. Dystonic motor and phonic tics in Tourette syndrome. J Neurol 2022; 269:5312.</a></li><li><a class="nounderline abstract_t">Lin JJ, Wang HS, Wong MC, et al. Tourette's syndrome with cervical disc herniation. Brain Dev 2007; 29:61.</a></li><li><a class="nounderline abstract_t">Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette's syndrome. Mov Disord 1996; 11:563.</a></li><li><a class="nounderline abstract_t">Dobbs M, Berger JR. Cervical myelopathy secondary to violent tics of Tourette's syndrome. Neurology 2003; 60:1862.</a></li><li><a class="nounderline abstract_t">Isaacs JD, Adams M, Lees AJ. Noncompressive myelopathy associated with violent axial tics of tourette syndrome. Neurology 2010; 74:697.</a></li><li><a class="nounderline abstract_t">van Meerbeeck P, Behar C, Czernecki V, et al. Motor tic of the neck: a probable cause of stroke in a child with Gilles de la Tourette syndrome. Mov Disord 2011; 26:928.</a></li><li><a class="nounderline abstract_t">Lehman LL, Gilbert DL, Leach JL, et al. Vertebral artery dissection leading to stroke caused by violent neck tics of Tourette syndrome. Neurology 2011; 77:1706.</a></li><li><a class="nounderline abstract_t">Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord 2011; 26:1149.</a></li><li><a class="nounderline abstract_t">Freeman RD, Zinner SH, Müller-Vahl KR, et al. Coprophenomena in Tourette syndrome. Dev Med Child Neurol 2009; 51:218.</a></li><li><a class="nounderline abstract_t">Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 2003; 18:1530.</a></li><li><a class="nounderline abstract_t">Lin H, Katsovich L, Ghebremichael M, et al. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J Child Psychol Psychiatry 2007; 48:157.</a></li><li><a class="nounderline abstract_t">Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998; 102:14.</a></li><li><a class="nounderline abstract_t">Robertson MM. The Gilles de la Tourette syndrome: the current status. Br J Psychiatry 1989; 154:147.</a></li><li><a class="nounderline abstract_t">Bloch MH, Peterson BS, Scahill L, et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006; 160:65.</a></li><li><a class="nounderline abstract_t">Erenberg G, Cruse RP, Rothner AD. The natural history of Tourette syndrome: a follow-up study. Ann Neurol 1987; 22:383.</a></li><li><a class="nounderline abstract_t">Groth C, Mol Debes N, Rask CU, et al. Course of Tourette Syndrome and Comorbidities in a Large Prospective Clinical Study. J Am Acad Child Adolesc Psychiatry 2017; 56:304.</a></li><li><a class="nounderline abstract_t">Mataix-Cols D, Isomura K, Brander G, et al. Early-Life and Family Risk Factors for Tic Disorder Persistence into Adulthood. Mov Disord 2023; 38:1419.</a></li><li><a class="nounderline abstract_t">Bagheri MM, Kerbeshian J, Burd L. Recognition and management of Tourette's syndrome and tic disorders. Am Fam Physician 1999; 59:2263.</a></li><li><a class="nounderline abstract_t">Jankovic J, Gelineau-Kattner R, Davidson A. Tourette's syndrome in adults. Mov Disord 2010; 25:2171.</a></li><li><a class="nounderline abstract_t">Jankovic J, Mejia NI. Tics associated with other disorders. Adv Neurol 2006; 99:61.</a></li><li><a class="nounderline abstract_t">Hirschtritt ME, Lee PC, Pauls DL, et al. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry 2015; 72:325.</a></li><li><a class="nounderline abstract_t">Baizabal-Carvallo JF, Alonso-Juarez M, Jankovic J. Self-injurious behavior in Tourette syndrome. J Neurol 2022; 269:2453.</a></li><li><a class="nounderline abstract_t">Kurlan R, Como PG, Miller B, et al. The behavioral spectrum of tic disorders: a community-based study. Neurology 2002; 59:414.</a></li><li><a class="nounderline abstract_t">Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019; 92:896.</a></li><li><a class="nounderline abstract_t">Comings DE, Comings BG. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet 1987; 41:701.</a></li><li><a class="nounderline abstract_t">Termine C, Luoni C, Fontolan S, et al. Impact of co-morbid attention-deficit and hyperactivity disorder on cognitive function in male children with Tourette syndrome: A controlled study. Psychiatry Res 2016; 243:263.</a></li><li><a class="nounderline abstract_t">Mataix-Cols D, Brander G, Chang Z, et al. Serious Transport Accidents in Tourette Syndrome or Chronic Tic Disorder. Mov Disord 2021; 36:188.</a></li><li><a class="nounderline abstract_t">Makhoul K, Jankovic J. Tourette Syndrome and Driving. Mov Disord Clin Pract 2021; 8:763.</a></li><li><a class="nounderline abstract_t">Andersen K, Groth C, Skov L, Debes NM. Childhood Comorbidity Severity Impacts Adolescent Substance Consumption in Patients With Tourette Syndrome. Pediatr Neurol 2023; 145:88.</a></li><li><a class="nounderline abstract_t">Martino D, Ganos C, Pringsheim TM. Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics. Int Rev Neurobiol 2017; 134:1461.</a></li><li><a class="nounderline abstract_t">Gaze C, Kepley HO, Walkup JT. Co-occurring psychiatric disorders in children and adolescents with Tourette syndrome. J Child Neurol 2006; 21:657.</a></li><li><a class="nounderline abstract_t">Lombroso PJ, Scahill L. Tourette syndrome and obsessive-compulsive disorder. Brain Dev 2008; 30:231.</a></li><li><a class="nounderline abstract_t">Chou IC, Lin HC, Lin CC, et al. Tourette syndrome and risk of depression: a population-based cohort study in Taiwan. J Dev Behav Pediatr 2013; 34:181.</a></li><li><a class="nounderline abstract_t">Fernández de la Cruz L, Rydell M, Runeson B, et al. Suicide in Tourette's and Chronic Tic Disorders. Biol Psychiatry 2017; 82:111.</a></li><li><a class="nounderline abstract_t">Budman CL, Rockmore L, Stokes J, Sossin M. Clinical phenomenology of episodic rage in children with Tourette syndrome. J Psychosom Res 2003; 55:59.</a></li><li><a class="nounderline abstract_t">Mol Debes NM. Co-morbid disorders in Tourette syndrome. Behav Neurol 2013; 27:7.</a></li><li><a class="nounderline abstract_t">Jankovic J, Kwak C, Frankoff R. Tourette's syndrome and the law. J Neuropsychiatry Clin Neurosci 2006; 18:86.</a></li><li><a class="nounderline abstract_t">Mataix-Cols D, Virtanen S, Sidorchuk A, et al. Association of Tourette Syndrome and Chronic Tic Disorder With Violent Assault and Criminal Convictions. JAMA Neurol 2022; 79:459.</a></li><li><a class="nounderline abstract_t">Huckeba W, Chapieski L, Hiscock M, Glaze D. Arithmetic performance in children with Tourette syndrome: relative contribution of cognitive and attentional factors. J Clin Exp Neuropsychol 2008; 30:410.</a></li><li><a class="nounderline abstract_t">Singer HS, Schuerholz LJ, Denckla MB. Learning difficulties in children with Tourette syndrome. J Child Neurol 1995; 10 Suppl 1:S58.</a></li><li><a class="nounderline abstract_t">Pérez-Vigil A, Fernández de la Cruz L, Brander G, et al. Association of Tourette Syndrome and Chronic Tic Disorders With Objective Indicators of Educational Attainment: A Population-Based Sibling Comparison Study. JAMA Neurol 2018; 75:1098.</a></li><li><a class="nounderline abstract_t">Lee WT, Huang HL, Wong LC, et al. Tourette Syndrome as an Independent Risk Factor for Subsequent Sleep Disorders in Children: A Nationwide Population-Based Case-Control Study. Sleep 2017; 40.</a></li><li><a class="nounderline abstract_t">Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Sleep disorders in tourette syndrome. Sleep Med Rev 2020; 53:101335.</a></li><li><a class="nounderline abstract_t">Brander G, Isomura K, Chang Z, et al. Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders. JAMA Neurol 2019; 76:454.</a></li><li><a class="nounderline abstract_t">Kwak C, Vuong KD, Jankovic J. Migraine headache in patients with Tourette syndrome. Arch Neurol 2003; 60:1595.</a></li><li><a class="nounderline abstract_t">Ghosh D, Rajan PV, Das D, et al. Headache in children with Tourette syndrome. J Pediatr 2012; 161:303.</a></li><li><a class="nounderline abstract_t">Barabas G, Matthews WS, Ferrari M. Tourette's syndrome and migraine. Arch Neurol 1984; 41:871.</a></li><li><a class="nounderline abstract_t">Isung J, Isomura K, Larsson H, et al. Association of Tourette Syndrome and Chronic Tic Disorder With Cervical Spine Disorders and Related Neurological Complications. JAMA Neurol 2021; 78:1205.</a></li><li><a class="nounderline abstract_t">Martino D, Pringsheim TM, Cavanna AE, et al. Systematic review of severity scales and screening instruments for tics: Critique and recommendations. Mov Disord 2017; 32:467.</a></li><li><a class="nounderline abstract_t">Tulen JH, Azzolini M, de Vries JA, et al. Quantitative study of spontaneous eye blinks and eye tics in Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry 1999; 67:800.</a></li><li><a class="nounderline abstract_t">Farber RH, Swerdlow NR, Clementz BA. Saccadic performance characteristics and the behavioural neurology of Tourette's syndrome. J Neurol Neurosurg Psychiatry 1999; 66:305.</a></li><li><a class="nounderline abstract_t">Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group. Arch Neurol 1993; 50:1013.</a></li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.</li><li><a class="nounderline abstract_t">Ganos C, Martino D, Espay AJ, et al. Tics and functional tic-like movements: Can we tell them apart? Neurology 2019; 93:750.</a></li><li><a class="nounderline abstract_t">Robertson MM, Banerjee S, Kurlan R, et al. The Tourette syndrome diagnostic confidence index: development and clinical associations. Neurology 1999; 53:2108.</a></li><li><a class="nounderline abstract_t">Jankovic J. Differential diagnosis and etiology of tics. Adv Neurol 2001; 85:15.</a></li><li><a class="nounderline abstract_t">Prado HS, Rosário MC, Lee J, et al. Sensory phenomena in obsessive-compulsive disorder and tic disorders: a review of the literature. CNS Spectr 2008; 13:425.</a></li><li><a class="nounderline abstract_t">Sanger TD, Chen D, Fehlings DL, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord 2010; 25:1538.</a></li></ol></div><div id="topicVersionRevision">Topic 6221 Version 44.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26918185" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Recent Advances in Understanding and Managing Tourette Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25392196" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31319731" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Controversies Surrounding the Pathophysiology of Tics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22440810" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The Gilles de la Tourette syndrome: the current status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11781410" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Disproportionate increases of white matter in right frontal lobe in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25820811" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Altered structure of cortical sulci in gilles de la Tourette syndrome: Further support for abnormal brain development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19913660" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21307354" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Abnormal metabolic brain networks in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32070809" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The role of the insula in the generation of motor tics and the experience of the premonitory urge-to-tic in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33244309" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Non-invasive Brain Stimulation for the Treatment of Gilles de la Tourette Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12695320" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Basal Ganglia volumes in patients with Gilles de la Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16247053" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19941350" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25264251" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34854494" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Frequency and Intensity of Premonitory Urges-to-Tic in Tourette Syndrome Is Associated With Supplementary Motor Area GABA+ Levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33349686" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Multivariate genome-wide analysis of education, socioeconomic status and brain phenome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19913658" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The genetics of Tourette syndrome: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22410579" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The genetics of Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16224024" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sequence variants in SLITRK1 are associated with Tourette's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20445167" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : L-histidine decarboxylase and Tourette's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18626069" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Histamine in the nervous system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25487709" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Population prevalence of Tourette syndrome: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36182698" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Systematic Review and Meta-Analysis of Tourette Syndrome Prevalence; 1986 to 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10972415" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19498335" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years - United States, 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22759682" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prevalence of tic disorders: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34672366" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Influence of sex on tic severity and psychiatric comorbidity profile in patients with pediatric tic disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33944988" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33944988" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18940377" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: the epidemiological and prevalence studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27566119" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prenatal Maternal Smoking and Increased Risk for Tourette Syndrome and Chronic Tic Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31356288" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Tics and Tourette Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35567613" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Dystonic motor and phonic tics in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17188440" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Tourette's syndrome with cervical disc herniation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8866498" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Severe motor tics causing cervical myelopathy in Tourette's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12796554" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cervical myelopathy secondary to violent tics of Tourette's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20177125" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Noncompressive myelopathy associated with violent axial tics of tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21370260" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Motor tic of the neck: a probable cause of stroke in a child with Gilles de la Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21975212" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Vertebral artery dissection leading to stroke caused by violent neck tics of Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21484868" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Tourette syndrome: evolving concepts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19183216" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Coprophenomena in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14673893" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Premonitory sensory phenomenon in Tourette's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17300554" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9651407" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Course of tic severity in Tourette syndrome: the first two decades.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2673473" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The Gilles de la Tourette syndrome: the current status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16389213" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3479043" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The natural history of Tourette syndrome: a follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28335874" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Course of Tourette Syndrome and Comorbidities in a Large Prospective Clinical Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37246931" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Early-Life and Family Risk Factors for Tic Disorder Persistence into Adulthood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10221310" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Recognition and management of Tourette's syndrome and tic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20690167" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Tourette's syndrome in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16536352" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Tics associated with other disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25671412" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34596744" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Self-injurious behavior in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12177376" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The behavioral spectrum of tic disorders: a community-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31061208" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2890294" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27423633" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Impact of co-morbid attention-deficit and hyperactivity disorder on cognitive function in male children with Tourette syndrome: A controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32969536" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Serious Transport Accidents in Tourette Syndrome or Chronic Tic Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34307750" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Tourette Syndrome and Driving.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37295060" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Childhood Comorbidity Severity Impacts Adolescent Substance Consumption in Patients With Tourette Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28805580" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16970866" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Co-occurring psychiatric disorders in children and adolescents with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17937978" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Tourette syndrome and obsessive-compulsive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23572168" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Tourette syndrome and risk of depression: a population-based cohort study in Taiwan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27773353" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Suicide in Tourette's and Chronic Tic Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12842232" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Clinical phenomenology of episodic rage in children with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23187139" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Co-morbid disorders in Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16525075" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Tourette's syndrome and the law.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35311941" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Association of Tourette Syndrome and Chronic Tic Disorder With Violent Assault and Criminal Convictions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18938679" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Arithmetic performance in children with Tourette syndrome: relative contribution of cognitive and attentional factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7751556" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Learning difficulties in children with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29813161" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Association of Tourette Syndrome and Chronic Tic Disorders With Objective Indicators of Educational Attainment: A Population-Based Sibling Comparison Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28364427" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Tourette Syndrome as an Independent Risk Factor for Subsequent Sleep Disorders in Children: A Nationwide Population-Based Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32554211" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Sleep disorders in tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30640363" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Association of Tourette Syndrome and Chronic Tic Disorder With Metabolic and Cardiovascular Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14623732" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Migraine headache in patients with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22424951" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Headache in children with Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6589980" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Tourette's syndrome and migraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34424277" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Association of Tourette Syndrome and Chronic Tic Disorder With Cervical Spine Disorders and Related Neurological Complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28071825" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Systematic review of severity scales and screening instruments for tics: Critique and recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10567503" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Quantitative study of spontaneous eye blinks and eye tics in Gilles de la Tourette's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10084528" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Saccadic performance characteristics and the behavioural neurology of Tourette's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8215958" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8215958" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31551261" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Tics and functional tic-like movements: Can we tell them apart?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10599790" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : The Tourette syndrome diagnostic confidence index: development and clinical associations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11530424" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Differential diagnosis and etiology of tics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18496480" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Sensory phenomena in obsessive-compulsive disorder and tic disorders: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20589866" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Definition and classification of hyperkinetic movements in childhood.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
